References
- Niemela O, Risteli L, Sotaniem E A, et al. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 1985; 15: 132–7
- Schuppan D, Besser M, Schwarting R, et al. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. J Clin Invest 1986; 78: 241–8
- International Group. Acute and chronic hepatitis revisited. Lancet 1977; 20: 914–9
- De Groote J, Desmet V J, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968; 2: 626–8
- Obata K, Iwata K, Ishida T, et al. One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin Chim Acta 1989; 181: 293–304
- Saito M, Hasegawa A, Kashiwakuma T, et al. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (cll/c7). Clin Chem 1992; 38: 2434–9
- Nakatsuji Y, Matsumoto A, Tanaka E, et al. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation recombinant immu-noblot assay and nested polymerase chain reaction analysis. Hepatology 1992; 16: 300–5
- Kwok S, Higuch R. Avoiding false positives with PCR. Nature 1989; 339: 237–8
- Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673–9
- Knodell R G, Isak K G, Black W C, et al. Formation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5
- Mishiro S, Hayashi S, Tanaka N, et al. Decrease in the zinc turbidity test values in the patients with liver cirrhosis: a possible indication for impending hepatocellular carcinoma. J Med 1983; 14: 185–92
- Hahn G, Wick G, Pencev D. et al. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin and flbronectin. Gut 1980; 21: 63–71
- Takahara T, Nakayama Y, Itoh H, et al. Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study. Liver 1992; 12: 368–80
- Ueno T, Inuzuka S, Torimura T, et al. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubized type IV collagen. Scand J Gastroenterol 1992; 27: 513–20
- Matsumoto E, Muragaki Y, Ooshima A. Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunosorbent assay with monoclonal antibodies. Jpn Soc Pathol 1989; 39: 217–23
- Niemela O, Risteli J, Blake J E, et al. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Gastroenterology 1990; 98: 1612–9
- Brillanti S, Garson J A, Tuke P W, et al. Effects of a-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. J Med Virol 1991; 34: 136–41
- Kerr J FR, Cooksley W GE, Searle J, et al. The nature of piecemeal necrosis in chronic active hepatitis. Lancet 1979; 2: 827–8
- Tsubouchi H, Nitani Y, Hirono S, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver disease determined by an enzyme-linked immunosorbent assav. Hepatology 1990; 13: 1–5
- Castilla A, Prieto J, Fausto N. Transforming growth factor-β1 and α in chronic liver disease: effects of interferon α therapy. N Engl J Med 1991; 324: 933–40
- Yoshioka T, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–9